Literature DB >> 23734680

miRNA: the new frontier in cancer medicine.

Jingfang Ju, Jingting Jiang, Andrew Fesler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23734680      PMCID: PMC3715138          DOI: 10.4155/fmc.13.74

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  20 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  Inhibition of translational initiation by Let-7 MicroRNA in human cells.

Authors:  Ramesh S Pillai; Suvendra N Bhattacharyya; Caroline G Artus; Tabea Zoller; Nicolas Cougot; Eugenia Basyuk; Edouard Bertrand; Witold Filipowicz
Journal:  Science       Date:  2005-08-04       Impact factor: 47.728

3.  Clarifications on miRNA and cancer.

Authors:  Gary Ruvkun
Journal:  Science       Date:  2006-01-06       Impact factor: 47.728

4.  Design of antisense oligonucleotides stabilized by locked nucleic acids.

Authors:  Jens Kurreck; Eliza Wyszko; Clemens Gillen; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

5.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

6.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans.

Authors:  B Wightman; I Ha; G Ruvkun
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

8.  Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.

Authors:  C Dony; M Kessel; P Gruss
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

9.  let-7 regulates self renewal and tumorigenicity of breast cancer cells.

Authors:  Fengyan Yu; Herui Yao; Pengcheng Zhu; Xiaoqin Zhang; Qiuhui Pan; Chang Gong; Yijun Huang; Xiaoqu Hu; Fengxi Su; Judy Lieberman; Erwei Song
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

10.  Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells.

Authors:  Chiachen Chen; Victoria Akerstrom; James Baus; Michael S Lan; Mary B Breslin
Journal:  Virol J       Date:  2013-03-14       Impact factor: 4.099

View more
  6 in total

1.  MicroRNAs as promising biomarkers in cancer diagnostics.

Authors:  Prasun J Mishra
Journal:  Biomark Res       Date:  2014-10-22

2.  Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.

Authors:  Xiao-Feng Tian; Fu-Jian Ji; Hong-Liang Zang; Hong Cao
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

3.  Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells.

Authors:  Ning Wu; Andrew Fesler; Hua Liu; Jingfang Ju
Journal:  Oncotarget       Date:  2017-11-06

4.  Improving classification of mature microRNA by solving class imbalance problem.

Authors:  Ying Wang; Xiaoye Li; Bairui Tao
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

Review 5.  The expanding regulatory universe of p53 in gastrointestinal cancer.

Authors:  Andrew Fesler; Ning Zhang; Jingfang Ju
Journal:  F1000Res       Date:  2016-04-26

6.  miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.

Authors:  Yunping Lu
Journal:  Comput Math Methods Med       Date:  2021-07-08       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.